Blood testing device for early diagnosis of cancer and treatment…
Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
Latest fiscal year, from the company’s SEC Form C filing · SEC Form C-AR ↗
What they do:
Enabling health professionals to prescribe clinical-grade wellness…
Quick facts:
HQ: Athens, Greece
What they do:
Cofactor closes the precision medicine gap with predictive diagnostics
Quick facts:
HQ: St. Louis, MO, United States
What they do:
Bringing non-invasive brain stimulation from the hospital to the home
Quick facts:
HQ: Mexico City, Mexico
What they do:
Redcliffe Labs is India's Largest Omni-channel Diagnostics platform
Quick facts:
What they do:
India's Fastest Diagnostics Service
Quick facts:
What they do:
Absorbable wrap for blood vessels
Quick facts:
HQ: Houston, TX, United States
Funding:
$10M · Debt · May 2026
Blood testing device for early diagnosis of cancer and treatment…
Monterrey, Mexico
18 employees, according to the company profile.
There are no funding rounds for Delee in our data.
Similar startups: PNOĒ, Cofactor Genomics, and Actipulse Neuroscience.